Also wtf is up with this course of sales... volume of 1 share pushing it down to 72 and then again pushing it down to 70... can someone flag this to the ASX.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%